JG
DFTX

Joel Greenblatt’s Definium Therapeutics DFTX Stock Holding History

Joel Greenblatt’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+4,412
New +$109K ﹤0.01% 1728
2026
Q1 		– Sell
-17,825
Closed -$239K – 1825
2025
Q4 		$239K Buy
17,825
+823
+5% +$10.2K ﹤0.01% 1626
2025
Q3 		$200K Buy
17,002
+2,924
+21% +$27.3K ﹤0.01% 1616
2025
Q2 		$91.4K Buy
+14,078
New +$92.6K ﹤0.01% 1620

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Joel Greenblatt's DFTX Position: Q2 2026 in Review

Joel Greenblatt opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 4,412 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #1728 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in DFTX as recently as Q4 2025.

Joel Greenblatt first reported a position in DFTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $239K in Q4 2025. 360 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Joel Greenblatt held 4,412 shares of Definium Therapeutics worth $208K as of Q2 2026.
  • Definium Therapeutics was a new Joel Greenblatt position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1728 holding.
  • Joel Greenblatt first reported a position in Definium Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Joel Greenblatt's Definium Therapeutics position peaked at $239K in Q4 2025.
  • 360 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.